Study Objectives: We tested the hypothesis that estradiol (E 2 ) protects against cardiorespiratory disorders and oxidative stress induced by chronic intermittent hypoxia (CIH) in adult female rats. Methods: Sprague-Dawley female rats (230-250 g) were ovariectomized and implanted with osmotic pumps delivering vehicle or E 2 (0.5 mg/kg/d). After 14 days of recovery, the rats were exposed to CIH (21%-10% O 2 : 8 h/d, 10 cycles per hour) or room air (RA). After 7 days of CIH or RA exposure, we measured arterial pressures (tail cuff), metabolic rate (indirect calorimetry), minute ventilation, the frequency of sighs and apneas at rest, and ventilatory responses to hypoxia and hypercapnia (whole body plethysmography). We collected the cerebral cortex, brainstem, and adrenal glands to measure the activity of NADPH and xanthine oxidase (pro-oxidant enzymes), glutathione peroxidase, and the mitochondrial and cytosolic superoxide dismutase (antioxidant enzymes) and measured lipid peroxidation and advanced oxidation protein products (markers of oxidative stress). Results: CIH increased arterial pressure, the frequency of apnea at rest, and the hypoxic and hypercapnic ventilatory responses and reduced metabolic rate. CIH also increased oxidant enzyme activities and decreased antioxidant activity in the cortex. E 2 treatment reduced body weight and prevented the effects of CIH. Conclusions: E 2 prevents cardiorespiratory disorders and oxidative stress induced by CIH. These observations may help to better understand the underlying mechanisms linking menopause and occurrence of sleep apnea in women and highlight a potential advantage of hormone therapy.
INTRODUCTION
One of the main features of sleep apnea is chronic intermittent hypoxemia which leads to an increased oxidative stress, defined as an imbalance between the production and elimination of reactive oxygen species (ROS), [1] [2] [3] [4] [5] [6] and oxidative stress appears as a major contributor to cardiovascular (hypertension, stroke), neurological (cognitive impairments, mood disorders), and metabolic (insulin resistance, type II diabetes) consequences observed in patients suffering from sleep apnea. 4, [7] [8] [9] [10] Animal models of sleep apnea demonstrate that exposure to intermittent hypoxia increased the hypoxic ventilatory response and induced arterial hypertension by enhancing the activity of peripheral chemoreceptors in response to hypoxia by a mechanism involving exaggerated ROS production. 2, 3, [11] [12] [13] Similarly, neuronal damage and cognitive impairment might be due to ROS overgeneration secondary to a mitochondrial dysfunction, leading to cytochrome c release from mitochondria and apoptosis. 14 The prevalence of sleep apnea is higher in men than in premenopausal women (with a men:women ratio of 2:1 to 3:1 15, 16 ) and its occurrence is three to four times higher in women after versus before menopause. [15] [16] [17] Epidemiological studies have reported that hormonal replacement therapy reduces the frequency of sleep apnea in postmenopausal women after adjustment for other known risk factors (age, body mass index, and neck circumference). 15, 18 However, a potential "healthy user bias" was recently suggested. 19 Netzer et al. 20 reported that plasma levels of ovarian hormones are inversely correlated with the frequency of obstructive sleep apnea while recent studies showed that in depressed women in peri-and postmenopause, low estradiol (E 2 ) level correlates with high frequency of apnea, 21 and in pregnant women, low progesterone level correlates with high apnea frequency. 22 In this context, progesterone is well known as a potent respiratory stimulant in humans and animal models (for review, see Joseph et al. 23 ), and the effects of progesterone on nuclear 24 and membrane receptors 25, 26 could contribute to reduce apnea frequency by increasing the respiratory drive in normoxia and in response to hypoxia or hypercapnia. While E 2 does not have a direct respiratory stimulant effect, 27 it could have complementary protective roles against the deleterious consequences of sleep apnea and intermittent hypoxia. For example, E 2 helps to maintain adequate contractile properties of the upper airways dilating muscles in adult female rats exposed to intermittent hypoxia. 28 E 2 is also a potent antioxidant that can reduce cellular ROS content. Indeed, in naturally menopausal rats, E 2 treatment increases the activity of the Cu-Zn superoxide dismutase enzyme (SOD Cu-Zn ) in different tissues including brain, heart, kidney, and uterus. 29 The main producers of ROS (in particular of the superoxide anion-O 2 − ) are the mitochondria, NADPH oxidase (NOX), and xanthine oxidase (XO), 4, 30 and E 2 also downregulates their activity. For example, mitochondrial ROS production in brain and liver is reduced by E 2 in male rats. 31 ,32 E 2 through its genomic receptors (ERα and ERβ) increases the expression and activity of the mitochondrial respiratory chain enzymes, leading to an increase of oxidative phosphorylation, a reduction of electron leaks, and, therefore, a decreased production of mitochondrial ROS. 33 ERα and ERβ have also been demonstrated to regulate the expression and activity of SOD. 33 Previous studies using adult female rats exposed to intermittent hypoxia have reported conflicting results. A recent study showed an increased arterial tension and respiratory instabilities after 35 days of exposure to intermittent hypoxia reaching 6% O 2 -every 9 minutes, 34 while it was previously reported that, compared to male or ovariectomized (OVX) female rats, intact females had a lower elevation of arterial blood pressure after 7 days (10% O 2 -every 6 minutes) of intermittent hypoxia. 35 In the present study, we tested the hypothesis that E 2 protects against oxidative stress induced by intermittent hypoxia in OVX female rats. We used systemic administration of E 2 to address the putative effects on peripheral chemoreceptors (which are involved in development of hypertension in intermittent hypoxia 2, 3, [11] [12] [13] ) and in the central nervous system, which is also an important target of oxidative stress in intermittent hypoxia. 7, 14 We measured arterial pressure, breathing pattern at rest and in response to hypoxia or hypercapnia (as an index of peripheral chemoreceptor responses), and activities of pro-and antioxidant enzyme in cytosolic and mitochondrial protein extracts in the central (cortex and brainstem) and peripheral (adrenal glands) nervous system after 7 days of chronic intermittent hypoxia (CIH) or room air (RA). Our results are consistent with the hypothesis that E 2 acts as a potent antioxidant in female rats exposed to CIH, preventing cardiorespiratory dysfunction.
MATERIALS AND METHODS

Ethical Approval
All experimental protocols have been approved by the animal protection committee of the Centre de Recherche du CHU de Québec in accordance with the Canadian Council on Animal Care in Science. We used a total of 40 Sprague-Dawley female rats (220-250 g, 57-70 days old) purchased at Charles Rivers Laboratories (Saint-Constant, Québec, Canada). All animals had ad libitum access to food and water and were maintained on a 12/12-hour light/dark cycle.
Experimental Group
We used four groups of adult female rats (10 females per group): two groups of OVX rats were treated with vehicle (2-hydroxypropyl-β-cyclodextrin, 200 µg/mL; Cayman Chemicals catalogue # 16169) and exposed either to RA (OVX-Veh RA) or CIH (OVXVeh CIH). The third group was OVX rats treated with 17β E 2 (0.5 mg/kg/d; Sigma-Aldrich catalogue # E8875) and exposed to CIH (OVX-E 2 CIH), and the fourth group was sham-operated rats treated with Veh and exposed to RA (Sham-Veh RA) serving as a control for the effect of OVX under RA conditions.
Surgical Procedures
Rats were anesthetized under isoflurane (4% induction then 2%) and the ovaries were removed through bilateral flank incisions. The level of anesthesia was verified before and during the surgery by the lack of reflex responses to frequent tail pinching. In sham-operated rats, the ovaries were left intact. The animals were implanted subcutaneously in the upper midback region with an osmotic pump (Alzet; model 2ML4-flow of 60 µL/d during 28 days) filled with Veh or 17β E 2 (0.5 mg/ kg/d-adjusted to body weight on the day of surgery). All animals received pre-and postoperative analgesics for 48 hours (bupevacaïne and lidocaine, subcutaneous injection, respectively, 3.5 and 7 mg/kg in 2.5 mL/kg) according to our normalized protocols.
CIH Exposure
After 2 weeks of recovery, the rats were housed in a Plexiglas chamber (internal volume 0.05 m 3 ), connected to an oxycycler (Biospherix, Redfield, NY). Oxygen dropped from 21% to 10% in 90 seconds, holding O 2 at 10% for 30 seconds, then returned to 21% in 70 seconds and holding at 21% for 120 seconds, at the rate of 10 cycles per hour for 8 consecutive hours between 8:30 am and 4:30 pm during 7 days. Rats exposed to RA were placed in the same room that those exposed to CIH.
Body Weight and Food Intake
Body weight and food intake were assessed weekly during 4 consecutive weeks starting 1 week before the surgery. For measurements of food intake, all rats were housed individually with a known amount of food. Every week, the amount of remaining food was weighed (including the food inside the cage if necessary), to calculate the energy intake for each animal in kilojoule per day per kilogram using the energy content of the food (13.80 Kj/g, Teklad Global 19% Protein Extruded Rodent Diet; Teklad Diets, Madison, WI).
Systemic Measurements
Arterial blood pressure and heart rate were measured by the tail-cuff method by volume pressure recording (CODA system; Kent Scientific, Torrington, CT) in conscious rats after exposure to CIH or RA between noon and 1:00 pm. The animal was placed in a restrainer tube over a warmed blanket. After 30 minutes of habituation, several recordings were performed, separated at least by 5 minutes. We have reported the mean of the three lowest values for systolic, diastolic, and mean arterial pressures. Tail-cuff recording requires restraint of the animal; however, this method is recognized as a reliable and accurate measure of arterial blood pressure compared to simultaneous telemetry measurements with a chronic aortic catheter.
36
Recording of Respiratory and Metabolic Parameters After 7 days of CIH or RA, animals were placed in a whole body flow-through plethysmograph chamber for adult rats (EMKA Technologies, Paris, France). The chamber was constantly flushed with RA (1500 mL/min), and a sub-sampling pump (75 mL/min) was used to collect outflowing air. A built-in pneumotachograph measured airflow related to breathing. Before the experiment, the chamber was calibrated via measurement of the airflow generated by the rapid injection of 0.5 mL of air. Water pressure, CO 2 , and O 2 levels in the outflowing air were continuously measured using specific gas analyzers (RH-300, CA-10, and FC-10; Sable Systems, Las Vegas, NV) calibrated using a certified dry gas mix (Linde Canada Limite, Vanier, Québec, Canada). Each hour during recordings, we also measured water pressure, CO 2 , and O 2 levels in the inflowing air, these values were used to calculate O 2 consumption and CO 2 production rate as previously described. 26 The temperature of the plethysmograph chamber was recorded with a thermocouple, and the rectal temperature of the rat was measured at the end of the recording. All signals were digitized (Micro 1401 data acquisition system; Cambridge Electronic Design, Cambridge, England) and stored on a computer running the Spike 2 software (version 7.06-CED). All measurements were performed continuously between 9:00 am and 1:00 pm, ensuring enough time to obtain respiratory and metabolic parameters reflecting a resting state and evaluate the frequency of apneas in periods of sleep, as assessed by behavioral (animals in curled-up position) and respiratory pattern criteria. 24, 26 Test of Chemoreflex Function After the recordings in normoxia, the animals were sequentially exposed to hypoxia (12% O 2 ) and hypercapnia (5% CO 2 ) for 10 minutes each separate by 10 minutes of normoxia. At the end of the recordings, the animals were deeply anesthetized by isoflurane (3%), the level of anesthesia was assessed by the lack of reflex responses to tail pinch, a sample of blood was taken by cardiac puncture, then the animals were sacrificed by decapitation, the cortex, brainstem, and adrenal glands were harvested, immediately frozen on dry ice, and stored at −80°C for further analysis. All pumps were removed, and we verified that the remaining volume in each pump was 0.5 mL as expected. Serum E 2 level was measured using an Elisa Immunoassay kit (Cayman Chemicals catalogue # 582251).
Data Analysis
Metabolism and Respiratory Parameters at Rest
We applied a standard approach to determine the resting state defined as the period of quiet and regular breathing pattern with the lowest respiratory frequency (fR) and CO 2 value in the outflowing gas line. Of note, the investigator performing the analysis was not blinded to the groups. O 2 consumption (VO 2 ) and CO 2 production (VCO 2 ) rate were calculated using the standard equations as described previously. 26 The respiratory exchange ratio (RER) was calculated as VCO 2 /VO 2 . O 2 consumption and CO 2 production were expressed as volume (mL) per minute and 100 g body weight in ambient conditions of atmospheric pressure, temperature, and water pressure.
Respiratory frequency (fR), tidal volume (V T ), and minute ventilation (V E ) were determined during periods of calm and regular breathing pattern without interruptions by sighs or apneas. V T was calculated as described previously 24, 26, 37 using the standard equation for whole body plethysmography and expressed as volume (mL) per 100 g body weight in body conditions of temperature, saturated with water pressure (BTPS).
Frequency of Sighs and Apneas and Variability of the Breathing Pattern at Rest
We selected a period of calm and regular breathing pattern lasting about 1 hour towards the end of the fourth hour of recording to evaluate the frequency of sighs, post-sigh, and spontaneous apneas. It should be noted that this likely reflects apneas occurring during REM and non-REM sleep. Sighs are characterized by a profound inspiration with a volume that is at least twice the normal tidal volume, and a rapid expiration that can be followed by apneas. Apneas are defined as two missed breaths. Post-sigh apneas occur immediately or a few seconds after the sigh (typically 5-6 seconds) while spontaneous apneas occur without preceding sigh. 24 Breathing variability was calculated by the Poincaré plot method for determining variability indexes SD1 and SD2 as described by Brennan et al. 38 For each animal, we averaged the variability indexes for two to three periods lasting about 400 breaths on a stable portion of the respiratory trace without sigh or apnea.
Test of Chemoreflex Function
We selected the longest period of stable breathing pattern with the lowest respiratory frequency during the last 5 minutes after the onset of exposure. All responses were expressed as percent increase compared to a baseline value measured before the exposure to test gas.
Oxidative Stress Enzyme Activities Protein Extraction and Assays
Protein fractions were extracted from frozen cortex, brainstem, and adrenal glands. After homogenization in phosphate buffer, different centrifugations (all at 4°C) were used to separate cytosolic and mitochondrial fractions. Briefly, the samples were centrifuged for 4 minutes at 1500g (the supernatant of this centrifugation was used to measure malondialdehyde [MDA] level-see below) followed by a second centrifugation for 10 minutes at 12 000g, and the supernatant (cytosolic fraction) was collected. The pellet was re-suspended in a mitochondrial isolation buffer (250 mM sucrose, 1 mM EGTA, 20 mM Tris base, pH 7.3) and centrifuged for 10 minutes at 1500g. Finally, a last centrifugation at 9000g for 10 minutes was performed and the pellet (mitochondrial fraction) was re-suspended in 200 µL of mitochondrial isolation buffer. These two fractions were stored at −80°C until analyses. The concentration of proteins in each fraction was determined by a standard colorimetric BCA assay kit (Thermo Scientific, catalogue # 23225) and all subsequent measurements were normalized to protein concentration.
Xanthine Oxidase XO activity was assessed using a cocktail containing nitroblue tetrazolium (NTB, 2.2 mM in water), Tris-HCL pH 8 (2.8 mM), and diethylene-triamine-penta-acetic acid (1.3 mM in Tris-HCL) and a fresh solution of hypoxanthine (500µM in Tris-HCL per well). Then, 50 µL of sample, 200 µL of cocktail, and 30 µL of hypoxanthine solutions were added to each well and the plate was gently shaken for 40 minutes at room temperature. The absorbance of the complex (formazan blue) formed by NTB and the superoxide anion produced by XO in the sample was read at 560 nm every 5 minutes for 1 hour; XO activity corresponded to the slope of the formation of formazan blue by the time.
NADPH Oxidase
NOX activity was assessed using a similar cocktail than for XO and NADPH 1mM (fresh solution). Then, 20 µL of sample, 250 µL of cocktail, and 30 µL (100 µM per well) of NADPH were added to each well and the plate was shaken 2 minutes at room temperature. The absorbance was read at 560 nm every 50 seconds for 10 minutes. NOX activity corresponded to the slope of the formation of formazan blue by the time Cytosolic and Mitochondrial SOD (SOD Cu-Zn and SOD Mn ) SOD activity was measured in cytosolic and mitochondrial fractions. SOD Cu-Zn activity was determined in the cytosolic fraction by the degree of inhibition of the reaction between O 2
•− produced by a hypoxanthine-XO system and NTB. We used the cocktail detailed for the XO and NOX activities plus hypoxanthine (0.19 mM). A fresh solution of XO (1.02 units/ mL) was prepared, then, we added 20 µL of sample, 250 µL of cocktail, and 20 µL of XO to each well, and mixed the plate for 4-5 seconds at room temperature. The absorbance was quickly read at 450 nm every 50 seconds for 5 minutes. SOD Mn activity was similarly determined in the mitochondrial fraction. For this assay, four wells were used as blanks, with 20 µL of PBS 1× rather than samples, and 1 mM of NaCN was added in all the wells to inhibit SOD Cu-Zn . SOD activity corresponded to the difference between the slopes of the formation of formazan blue by the time of the blank and each sample.
Glutathione Peroxidase
Activity of glutathione peroxidase (GPX) was determined as the rate of oxidation of NADPH to NADP + in a cocktail solution containing glutathione reductase, NADPH (1.7 mM), and reduced glutathione (1.6 mM in water) using H 2 O 2 (0.036% in water) as substrate. 39 We added 20 µL of sample, 200 µL of PBS 1×, 30 µL of the cocktail solution, and 30 µL of H 2 O 2 solution to each well and mix the plate 4-5 seconds at room temperature. The absorbance was quickly read at 340 nm every 50 seconds for 5 minutes. GPX activity was measured as the slope of the NADPH extinction by time.
Makers of Oxidative Stress
Advanced Oxidation Protein Products
Advanced oxidation protein products (AOPP) are markers of protein oxidation, they were measured according to the semi-automated methods developed by Witko-Sarsat et al. 40 The cytosolic concentrations of AOPP were determined by spectrophotometry and were calibrated with a chloramine-T solution that absorbs at 340 nm in the presence of potassium iodide (KI). The absorbance of the reaction mixture was immediately read at 340 nm on the microplate reader against a blank containing PBS, KI, and acetic acid.
Malondialdehyde
MDA is a marker of lipids peroxidation regularly used for evaluating oxidative stress. Concentrations of MDA were determined as described by Pialoux et al. 41 Briefly, the pink chromogen was extracted with n-butanol and its absorbance was measured at 532 nm by spectrophotometry. MDA concentration was calculated using 1,1,3,3-tetraethoxypropane as standard.
Statistical Analysis
We used GraphPad prism software for all analyses. All data were analyzed using a one-way ANOVA followed by a post hoc test (Fisher's Least Significance Difference). All data are Role of Ovariectomy, CIH, and E 2 on Body Weight and Energy Intake All animals were weighed 1 week before the surgery, on the day of surgery, and all subsequent weeks. Weight differences were apparent on the day of surgery (Figure 1A ), but all animals had a similar weight gain and energy intake the preceding week ( Figure 1B and C) . On the first week after the surgery, the animals treated with E 2 lose weight ( Figure 1B) and had a reduced energy intake ( Figure 1C ). Compared to sham-operated rats, OVX rats had an increased weekly weight gain during the second and third week post-surgery without altered energy intake. These effects of OVX and E 2 treatment were expected and are well known in female rats. 42 Weekly weight gain was lower in OVX rats exposed to CIH than in OVX rats exposed to RA (Figure 1B ), but the energy intake was similar between groups ( Figure 1C ). Rats exposed to CIH had lower VO 2 and VCO 2 at rest than non-exposed rats (Figure 2A and B) , and the RER was increased in OVX-Veh CIH rats compared to Sham-Veh RA rats ( Figure 2C ). E 2 treatment prevented the decrease of metabolic rate induced by CIH and restored a low VCO 2 /VO 2 .
RESULTS
Minute ventilation was lower in OVX-Veh RA rats than in sham rats ( Figure 2D ) due to a concomitant (but not significant) decrease of respiratory frequency and tidal volume ( Figure 2E and F). In rats exposed to CIH, tidal volume was higher in rats treated with E 2 than in rats treated with Veh ( Figure 2F) . V E /VO 2 was higher in OVX-Veh rats exposed to CIH than in OVX-Veh rats exposed to RA (Figure 2G ), but there was no significant change of V E /VCO 2 ( Figure 2H ).
E 2 Prevents the Increase of Arterial Pressure and Heart Rate Induced by CIH
Compared to OVX and sham rats exposed to RA, the mean, diastolic and systolic arterial pressures ( Figure 3A-C) , and heart rate ( Figure 3D ) were higher in rats exposed to CIH. In rats treated with E 2 and exposed to CIH, arterial pressure remained at a normal level ( Figure 3A-C) , and heart rate was lower compared to OVX and sham rats exposed to RA ( Figure 3D ). Compared to sham-operated animals exposed to RA, ovariectomy alone had no effect on MAP. 
E 2 Reduces the Frequency of Sighs and Apneas and Promotes Stability of the Breathing Pattern During Exposure to Chronic Intermittent Hypoxia
The frequency of sighs ( Figure 4 ) and post-sigh apnea ( Figure 5 ) were higher in OVX-Veh RA compared to Sham-Veh RA demonstrating an effect of OVX. Exposure to CIH further increased the frequency of sighs, post-sigh, and spontaneous apneas (Figures 4 and 5A-C). Rats exposed to CIH and treated with E 2 had a lower frequency of sighs and apneas compared to OVX-Veh CIH rats. No difference was observed for the mean apnea duration ( Figure 5C ). The breath-by-breath stability of the breathing pattern was evaluated on about 400 regular breaths. Examples of Poincaré plots are represented in Figure 6A . Compared to Sham-Veh RA and OVX-Veh RA, the variability indexes SD1 and SD2 was higher in OVX-Veh CIH rats, whereas with E 2 , there is no difference observed ( Figure 6B ).
E 2 Prevents the Increase of Chemoreflex Function During Exposure to CIH
The responses to hypercapnia (5% CO 2 ) and hypoxia (12% O 2 ) were higher in OVX-Veh CIH rats compared to Sham-Veh RA ( Figure 7A ). This is mainly due to the increase of fR rather than V T ( Figure 7B and C). E 2 treatment blunted this increase in hypoxia but not in hypercapnia, thus suggesting an effect of E 2 on the carotid bodies, the main sensor of arterial O 2 pressure.
E 2 Protects Against Pro-oxidant Status During Exposure to CIH
The activity of NOX was increased in the cortex and brainstem in animals exposed to CIH ( Figure 8A ) compared to Sham-Veh RA and OVX-Veh RA and E 2 treatment suppressed this effect. In the adrenals, there was no significant effect of CIH exposure . Individual values that are below or above the 25th or 75th percentile ± 1.5 the interpercentile range are indicated as black dots (below or above the box). *p < .05, ***p < .001, and ****p < .0001 vs. corresponding group as noted.
but in animals exposed to CIH, the activity of NOX was lower in animals treated with E 2 than in animals exposed to CIH. In contrast, there was no effect of CIH on XO activity. It should be acknowledged that we failed to detect XO activity in the brainstem. In the adrenal gland, XO activity was higher in OVX-Veh CIH rats but not in OVX-E 2 CIH compared to OVX-Veh RA ( Figure 8B ). The activity of both GPX and SOD Cu-Zn (two cytosolic antioxidant enzymes) was lower in the cortex after exposure to CIH. This decrease was prevented by E 2 treatment ( Figure 9A and B). We did not observe significant effect in the brainstem or adrenals. For cortical SOD Mn , the rats exposed to CIH have a tendency to express the lowest values of the four groups and in animals exposed to CIH SOD Mn activity was higher in rats treated with E 2 than in rats treated with Veh ( Figure 9C) .
The NADPH/SOD Cu-Zn ratio was higher in OVX-Veh CIH in the cortex and the brainstem compared to the other group ( Figure 10A ). This result is due to the increase of NOX activity and the diminution of SOD activity in rats treated with Veh and exposed to CIH.
In the brainstem and in the cortex, there was a higher level of MDA in rats exposed to CIH compared with controls and this increase was prevented by E 2 treatment. In the adrenals, the level of MDA was also increased by exposure to CIH but E 2 treatment did not prevent this effect. Regarding AOPP, no difference was found between each group ( Figure 10C ).
DISCUSSION
We report in the present study that E 2 supplementation protects against the development of hypertension, respiratory disorders, and oxidative stress in the central nervous system and adrenal glands in female rats exposed to CIH. E 2 treatment during exposure to CIH also prevents against the decrease of metabolic rate and maintains the RER at a low level. Overall, these data suggest that E 2 could be a potential candidate target to protect women against the deleterious consequences of sleep apnea and suggest that endogenous E 2 plays a protective role in premenopausal women by contributing to the lower occurrence of sleep apnea, and the associated oxidative stress. 17, 43 This hypothesis is strengthened by studies showing that in women, low level of E 2 correlates with high frequency of sleep apnea. 20 ,21 Our data also indicate that compared to the sham control group, OVX leads to a lower minute ventilation at rest and a higher frequency of sighs and post-sigh apneas. However, this group does not allow determining whether E 2 or progesterone contributes to this effect, but we might emphasize that compared to the sham group, the perturbations induced by CIH exposure were higher than those induced by OVX alone. As expected, E 2 treatment reduces food intake and body weight, an effect that mostly depends upon reduction of meal size mediated by the effects of E 2 on feeding behavior circuits of the central nervous system. 42, 44 One may argue that the lower body weight, and possible reduction of adipose tissue induced Figure 8 -Activity of NADPH oxidase (NOX: A) and xanthine oxidase (XO: B-all in nmol/min/µg proteins) in the cortex, brainstem, and adrenal glands of sham or ovariectomized (OVX) female rats, treated with vehicle (Veh) or estradiol (E 2 ), and exposed to room air (RA) or chronic intermittent hypoxia (CIH). Tukey plots show median (central line), 25th and 75th percentile (lower and upper box limits), and maximum and minimum values (error bars). *p < .05, **p < .01, ***p < .001, and ****p < .0001 vs. corresponding group as noted. by E 2 treatment, might contribute to reduce arterial pressure and oxidative stress. However, in subsequent experiments, we have treated OVX female rats exposed to CIH with a selective agonist of E 2 receptor alpha and found a reduced blood pressure (published in a recent review paper, see Boukari et al. 45 ), without alteration of body weight (321 ± 26 vs. 314 ± 17 g in OVXVeh CIH-body weight data were not included in the review paper), showing that, at least for blood pressure, the effects of E 2 in our CIH model do not depend on a reduction of body weight. Furthermore, in human, progesterone reduces apnea frequency after adjustment for the effects of known confounding factors, including body weight, in postmenopausal women 18 or during pregnancy, 22 showing that the effects of steroid on apnea frequency might not depend on body weight. On the Figure 9 -Activity of glutathione peroxidase (GPX: A) and superoxide dismutase (SOD) in cytosolic (B) or mitochondrial fractions (C-all in nmol/min/µg proteins) from the cortex, brainstem, and adrenal glands of sham or ovariectomized (OVX) female rats, treated with vehicle (Veh) or estradiol (E 2 ), and exposed to room air (RA) or chronic intermittent hypoxia (CIH). Tukey plots show median (central line), 25th and 75th percentile (lower and upper box limits), and maximum and minimum values (error bars). Individual values that are below or above the 25th or 75th percentile ± 1.5 the interpercentile range are indicated as black dots (below or above the box). *p < .05 and **p < .01 vs. corresponding group as noted.
other hand, it is becoming increasingly clear that dysfunction and inflammation of visceral adipose tissue contributes to the metabolic consequences of CIH, 46, 47 and it might be argued that the reduced adipose tissue mass induced by E 2 treatment during CIH contributes to its protective effects. Assessing the potential interactions between adipose functions, metabolic disturbances, and hormonal status in animal exposed to CIH is an appealing avenue of research. Exposure to CIH in rodents is regularly used to mimic sleep apnea 3, 6, 12, 13, 48 and the systemic manifestations seen in apneic patients. 5 Our results are consistent with previous studies showing that CIH induces an elevation of the hypoxic ventilatory response. 13, 48 This is mostly due to an increased activity and hypoxic responsiveness of the peripheral chemoreceptors, 49 that also leads to increased activity of the sympathetic system and arterial hypertension. 50, 51 Our results are also consistent with previous studies reporting that the increased O 2 sensitivity of peripheral chemoreceptors is involved in the instability of the breathing pattern, elevated apnea frequency, and hypertension observed in CIH. 50, [52] [53] [54] Indeed we observed that CIH increased the frequency of apneas, the breath-to-breath variability, and the frequency of sighs recorded at rest.
We previously showed that in adult female mice sighs recorded during sleep were associated with micro-arousals (up to 5 seconds-assessed by electromyogram/electroencephalogram electrodes), a sign of sleep fragmentation and poor sleep quality. 24 Although we have not recorded sleep/wake states in the current study, we reported in adult female mice that prolonged periods of stable and regular breathing pattern were associated with non-REM sleep. 24 Therefore, we might argue that the enhanced sigh frequency observed after exposure to CIH could also represent an increased frequency of micro-arousals. Interestingly, it has been reported that intermittent hypoxia leads to hyper somnolence and increased sleep propensity through an increase in NOX activity in regions containing wake-active neurons. 55 It could be thus hypothesized that the increased NOX activity in these regions may also increase micro-arousals and sighs frequency. By reducing NOX activity, E 2 could reduce these two features in animals exposed to CIH.
At the cellular level, CIH is associated with generation of ROS in the peripheral chemoreceptors, adrenal medulla, and in the brainstem areas that receive the terminal nerves from the carotid bodies. 3, 5, 6, 11, 12, 51 In the peripheral chemoreceptors of rats exposed to CIH, the expression of the NOX family members Nox1, Nox2, and Nox3 is increased. 12, 49, 56, 57 This enzymatic induction is mediated by increased expression of hypoxia-inducible factor-1α (HIF-1α), while the downregulation of SOD Mn is mediated by a reduced expression of HIF-2α. 58 Treatments of rats exposed to CIH with different antioxidant drugs including MnTMPyP (manganese tetrakis(1-methyl-4-pyridyl) porphyrin pentachloride-a membrane-permeable O 2 − scavenger) or apocynin (an inhibitor of NOX) have been shown to blunt the exaggerated hypoxic responses of the peripheral chemoreceptors and prevent the increase in sympathetic activity, mean arterial pressure, 2, 12 and apnea frequency. 52 Other antioxidant molecules such as ascorbic acid also prevent the development of hypertension in rats exposed to CIH, 3 and inhibitors of NADPH or XO in rats prevent the elevation of hypoxic ventilatory response and the decrease of metabolic rate after exposure to CIH. 13 Clinical studies are consistent with these data, and it has been shown in apneic patients that treatment with a XO inhibitor reduces vascular dysfunction. 59 Consistently with these previous studies, our results show that CIH increased the activity of NOX in the central nervous system (cortex and brainstem) and increased the activity of XO in the adrenal glands. CIH also decreased the activity of GPX and SOD in the cortex, but not in the brainstem or in the adrenal glands. As a consequence, the cortex appears to be more sensitive to CIH in regard to oxidative stress, which is reflected by the highest ratio of NOX to SOD Cu-Zn activity. It has been reported that CIH enhanced NAPDH oxidase activity and reduced SOD activity in brainstem regions that receive the afferent inputs from the peripheral chemoreceptors in the nucleus tractus solitarius and in the ventrolateral medulla 53 but not in neighboring brainstem regions. These effects are not reported after chemodenervation, suggesting that in the brainstem, oxidative stress is due to the enhanced activity of the peripheral chemoreceptors, 53 at least in the regions that receive the afferent inputs from the peripheral chemoreceptors. However, our results show that CIH enhances NOX activity in the brainstem and leads to higher MDA levels. Because we used whole brainstem samples, we cannot state if this response is homogenous across the organ or region specific. 53 The assessment of the protein content of NOX subunit at the origin of superoxide production and its activity in specific arera of the brain involved in respiratory should be performed in further studies to better understand the role of E 2 in the regulation of ventilation and oxidative stress. Nonetheless, the modulation of antioxidant enzyme activities in the cortex by CIH suggests a direct oxidative stress effect, independently of peripheral chemoreceptors activity. In our study, E 2 prevents the changes of antioxidant enzyme activities in the cortex and brainstem. Although the antioxidant enzyme activities were not measured in peripheral chemoreceptors, we can speculate that E 2 could also act at this level to reduce oxidative stress damages, contributing to its protective effects against elevated blood pressure and respiratory disorders induced by CIH.
Finally, it is worth mentioning that in the peripheral chemoreceptors of rats exposed to intermittent hypoxia (IH), the activity of the complex I of the mitochondrial electron transport chain is reduced and may thus lead to elevated mitochondrial ROS production. 49, 56 Another study suggested that in newborn mice, exposure to IH induces neuronal death by increased ROS production due to a reduced mitochondrial and complex I respiratory activity.
14 Our results are in line with these previous studies, showing a decreased activity of SOD in the mitochondrial fraction, which could contribute to exaggerated ROS production. It seems particularly important to note that E 2 enhances mitochondrial respiration, avoids excessive mitochondrial ROS production, 60 and specifically increases the activity of mitochondrial SOD. 61 Therefore, it might be hypothesized that E 2 protects against "mitochondrial dysfunction" induced by CIH, a state of mitochondrial function characterized by low activity of the electron transport chain, leading to high electron leak and elevated ROS production by electron transport chain complexes I and III. 62 Interestingly, our data show that CIH also increased the hypercapnic ventilatory response, but this effect was not suppressed by E 2 treatment. Previous studies in mice also reported that CIH increased the hypoxic and hypercapnic ventilatory responses, and that HIF-1α and ROS production are required to elevate the hypoxic but not the hypercapnic ventilatory response. 63 This suggests that E 2 could also reduce HIF-1α expression in CIH, as shown previously in response to hypoxia in Hep3B cells. 64 In conclusion, E 2 can protect against respiratory dysfunctions and is able to prevent the elevation of arterial blood pressure induced by intermittent hypoxia in female rats. E 2 also efficiently protects against oxidative stress in the central and
